Click for best price
Sphingosine1Receptor Modulators Drugs Market Size, Share 2023
Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belongs to a sphingosine-1-phosphate receptor subfamily comprising five members (S1PR1-5). S1PR1 was originally identified as an abundant transcript in endothelial cells and it has an important role in regulating endothelial cell cytoskeletal structure, migration, capillary-like network formation and vascular maturation. In addition, S1PR1 signaling is important in the regulation of lymphocyte maturation, migration and trafficking.
This report aims to provide a comprehensive presentation of the global market for Sphingosine-1-Receptor Modulators Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Sphingosine-1-Receptor Modulators Drugs. This report contains market size and forecasts of Sphingosine-1-Receptor Modulators Drugs in global, including the following market information:
Global Sphingosine-1-Receptor Modulators Drugs Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global Sphingosine-1-Receptor Modulators Drugs Market Sales, 2018-2023, 2024-2030, (K Units)
Global top five Sphingosine-1-Receptor Modulators Drugs companies in 2022 (%)
The global Sphingosine-1-Receptor Modulators Drugs market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Fingolimod Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Sphingosine-1-Receptor Modulators Drugs include Novartis, Bristol-Myers Squibb, Johnson & Johnson, Arena Pharmaceuticals, Idorsia, Sun Pharma, Biocon and HEC Pharm Co. Limited, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Sphingosine-1-Receptor Modulators Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Sphingosine-1-Receptor Modulators Drugs Market, by Type, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Sphingosine-1-Receptor Modulators Drugs Market Segment Percentages, by Type, 2022 (%)
Fingolimod
Siponimod
Ozanimod
Other
Global Sphingosine-1-Receptor Modulators Drugs Market, by Application, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Sphingosine-1-Receptor Modulators Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Other
Global Sphingosine-1-Receptor Modulators Drugs Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions) & (K Units)
Global Sphingosine-1-Receptor Modulators Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Sphingosine-1-Receptor Modulators Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Sphingosine-1-Receptor Modulators Drugs revenues share in global market, 2022 (%)
Key companies Sphingosine-1-Receptor Modulators Drugs sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Sphingosine-1-Receptor Modulators Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis
Bristol-Myers Squibb
Johnson & Johnson
Arena Pharmaceuticals
Idorsia
Sun Pharma
Biocon
HEC Pharm Co. Limited
Outline of Major Chapters:
Chapter 1: Introduces the definition of Sphingosine-1-Receptor Modulators Drugs, market overview.
Chapter 2: Global Sphingosine-1-Receptor Modulators Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Sphingosine-1-Receptor Modulators Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Sphingosine-1-Receptor Modulators Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Sphingosine-1-Receptor Modulators Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Sphingosine-1-Receptor Modulators Drugs Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
78 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Sphingosine-1-Receptor Modulators Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Sphingosine-1-Receptor Modulators Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Sphingosine-1-Receptor Modulators Drugs Overall Market Size
2.1 Global Sphingosine-1-Receptor Modulators Drugs Market Size: 2022 VS 2030
2.2 Global Sphingosine-1-Receptor Modulators Drugs Revenue, Prospects & Forecasts: 2018-2030
2.3 Global Sphingosine-1-Receptor Modulators Drugs Sales: 2018-2030
3 Company Landscape
3.1 Top Sphingosine-1-Receptor Modulators Drugs Players in Global Market
3.2 Top Global Sphingosine-1-Receptor Modulators Drugs Companies Ranked by Revenue
3.3 Global Sphingosine-1-Receptor Modulators Drugs Revenue by Companies
3.4 Global Sphingosine-1-Receptor Modulators Drugs Sales by Companies
3.5 Global Sphingosine-1-Receptor Modulators Drugs Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Sphingosine-1-Receptor Modulators Drugs Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Sphingosine-1-Receptor Modulators Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 Sphingosine-1-Receptor Modulators Drugs Players in Global Market
3.8.1 List of Global Tier 1 Sphingosine-1-Receptor Modulators Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 Sphingosine-1-Receptor Modulators Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Sphingosine-1-Receptor Modulators Drugs Market Size Markets, 2022 & 2030
4.1.2 Fingolimod
4.1.3 Siponimod
4.1.4 Ozanimod
4.1.5 Other
4.2 By Type - Global Sphingosine-1-Receptor Modulators Drugs Revenue & Forecasts
4.2.1 By Type - Global Sphingosine-1-Receptor Modulators Drugs Revenue, 2018-2023
4.2.2 By Type - Global Sphingosine-1-Receptor Modulators Drugs Revenue, 2024-2030
4.2.3 By Type - Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share, 2018-2030
4.3 By Type - Global Sphingosine-1-Receptor Modulators Drugs Sales & Forecasts
4.3.1 By Type - Global Sphingosine-1-Receptor Modulators Drugs Sales, 2018-2023
4.3.2 By Type - Global Sphingosine-1-Receptor Modulators Drugs Sales, 2024-2030
4.3.3 By Type - Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share, 2018-2030
4.4 By Type - Global Sphingosine-1-Receptor Modulators Drugs Price (Manufacturers Selling Prices), 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Sphingosine-1-Receptor Modulators Drugs Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Other
5.2 By Application - Global Sphingosine-1-Receptor Modulators Drugs Revenue & Forecasts
5.2.1 By Application - Global Sphingosine-1-Receptor Modulators Drugs Revenue, 2018-2023
5.2.2 By Application - Global Sphingosine-1-Receptor Modulators Drugs Revenue, 2024-2030
5.2.3 By Application - Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share, 2018-2030
5.3 By Application - Global Sphingosine-1-Receptor Modulators Drugs Sales & Forecasts
5.3.1 By Application - Global Sphingosine-1-Receptor Modulators Drugs Sales, 2018-2023
5.3.2 By Application - Global Sphingosine-1-Receptor Modulators Drugs Sales, 2024-2030
5.3.3 By Application - Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share, 2018-2030
5.4 By Application - Global Sphingosine-1-Receptor Modulators Drugs Price (Manufacturers Selling Prices), 2018-2030
6 Sights by Region
6.1 By Region - Global Sphingosine-1-Receptor Modulators Drugs Market Size, 2022 & 2030
6.2 By Region - Global Sphingosine-1-Receptor Modulators Drugs Revenue & Forecasts
6.2.1 By Region - Global Sphingosine-1-Receptor Modulators Drugs Revenue, 2018-2023
6.2.2 By Region - Global Sphingosine-1-Receptor Modulators Drugs Revenue, 2024-2030
6.2.3 By Region - Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share, 2018-2030
6.3 By Region - Global Sphingosine-1-Receptor Modulators Drugs Sales & Forecasts
6.3.1 By Region - Global Sphingosine-1-Receptor Modulators Drugs Sales, 2018-2023
6.3.2 By Region - Global Sphingosine-1-Receptor Modulators Drugs Sales, 2024-2030
6.3.3 By Region - Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share, 2018-2030
6.4 North America
6.4.1 By Country - North America Sphingosine-1-Receptor Modulators Drugs Revenue, 2018-2030
6.4.2 By Country - North America Sphingosine-1-Receptor Modulators Drugs Sales, 2018-2030
6.4.3 US Sphingosine-1-Receptor Modulators Drugs Market Size, 2018-2030
6.4.4 Canada Sphingosine-1-Receptor Modulators Drugs Market Size, 2018-2030
6.4.5 Mexico Sphingosine-1-Receptor Modulators Drugs Market Size, 2018-2030
6.5 Europe
6.5.1 By Country - Europe Sphingosine-1-Receptor Modulators Drugs Revenue, 2018-2030
6.5.2 By Country - Europe Sphingosine-1-Receptor Modulators Drugs Sales, 2018-2030
6.5.3 Germany Sphingosine-1-Receptor Modulators Drugs Market Size, 2018-2030
6.5.4 France Sphingosine-1-Receptor Modulators Drugs Market Size, 2018-2030
6.5.5 U.K. Sphingosine-1-Receptor Modulators Drugs Market Size, 2018-2030
6.5.6 Italy Sphingosine-1-Receptor Modulators Drugs Market Size, 2018-2030
6.5.7 Russia Sphingosine-1-Receptor Modulators Drugs Market Size, 2018-2030
6.5.8 Nordic Countries Sphingosine-1-Receptor Modulators Drugs Market Size, 2018-2030
6.5.9 Benelux Sphingosine-1-Receptor Modulators Drugs Market Size, 2018-2030
6.6 Asia
6.6.1 By Region - Asia Sphingosine-1-Receptor Modulators Drugs Revenue, 2018-2030
6.6.2 By Region - Asia Sphingosine-1-Receptor Modulators Drugs Sales, 2018-2030
6.6.3 China Sphingosine-1-Receptor Modulators Drugs Market Size, 2018-2030
6.6.4 Japan Sphingosine-1-Receptor Modulators Drugs Market Size, 2018-2030
6.6.5 South Korea Sphingosine-1-Receptor Modulators Drugs Market Size, 2018-2030
6.6.6 Southeast Asia Sphingosine-1-Receptor Modulators Drugs Market Size, 2018-2030
6.6.7 India Sphingosine-1-Receptor Modulators Drugs Market Size, 2018-2030
6.7 South America
6.7.1 By Country - South America Sphingosine-1-Receptor Modulators Drugs Revenue, 2018-2030
6.7.2 By Country - South America Sphingosine-1-Receptor Modulators Drugs Sales, 2018-2030
6.7.3 Brazil Sphingosine-1-Receptor Modulators Drugs Market Size, 2018-2030
6.7.4 Argentina Sphingosine-1-Receptor Modulators Drugs Market Size, 2018-2030
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Revenue, 2018-2030
6.8.2 By Country - Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales, 2018-2030
6.8.3 Turkey Sphingosine-1-Receptor Modulators Drugs Market Size, 2018-2030
6.8.4 Israel Sphingosine-1-Receptor Modulators Drugs Market Size, 2018-2030
6.8.5 Saudi Arabia Sphingosine-1-Receptor Modulators Drugs Market Size, 2018-2030
6.8.6 UAE Sphingosine-1-Receptor Modulators Drugs Market Size, 2018-2030
7 Manufacturers & Brands Profiles
7.1 Novartis
7.1.1 Novartis Company Summary
7.1.2 Novartis Business Overview
7.1.3 Novartis Sphingosine-1-Receptor Modulators Drugs Major Product Offerings
7.1.4 Novartis Sphingosine-1-Receptor Modulators Drugs Sales and Revenue in Global (2018-2023)
7.1.5 Novartis Key News & Latest Developments
7.2 Bristol-Myers Squibb
7.2.1 Bristol-Myers Squibb Company Summary
7.2.2 Bristol-Myers Squibb Business Overview
7.2.3 Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Major Product Offerings
7.2.4 Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Sales and Revenue in Global (2018-2023)
7.2.5 Bristol-Myers Squibb Key News & Latest Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson Company Summary
7.3.2 Johnson & Johnson Business Overview
7.3.3 Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Major Product Offerings
7.3.4 Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Sales and Revenue in Global (2018-2023)
7.3.5 Johnson & Johnson Key News & Latest Developments
7.4 Arena Pharmaceuticals
7.4.1 Arena Pharmaceuticals Company Summary
7.4.2 Arena Pharmaceuticals Business Overview
7.4.3 Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Major Product Offerings
7.4.4 Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Sales and Revenue in Global (2018-2023)
7.4.5 Arena Pharmaceuticals Key News & Latest Developments
7.5 Idorsia
7.5.1 Idorsia Company Summary
7.5.2 Idorsia Business Overview
7.5.3 Idorsia Sphingosine-1-Receptor Modulators Drugs Major Product Offerings
7.5.4 Idorsia Sphingosine-1-Receptor Modulators Drugs Sales and Revenue in Global (2018-2023)
7.5.5 Idorsia Key News & Latest Developments
7.6 Sun Pharma
7.6.1 Sun Pharma Company Summary
7.6.2 Sun Pharma Business Overview
7.6.3 Sun Pharma Sphingosine-1-Receptor Modulators Drugs Major Product Offerings
7.6.4 Sun Pharma Sphingosine-1-Receptor Modulators Drugs Sales and Revenue in Global (2018-2023)
7.6.5 Sun Pharma Key News & Latest Developments
7.7 Biocon
7.7.1 Biocon Company Summary
7.7.2 Biocon Business Overview
7.7.3 Biocon Sphingosine-1-Receptor Modulators Drugs Major Product Offerings
7.7.4 Biocon Sphingosine-1-Receptor Modulators Drugs Sales and Revenue in Global (2018-2023)
7.7.5 Biocon Key News & Latest Developments
7.8 HEC Pharm Co. Limited
7.8.1 HEC Pharm Co. Limited Company Summary
7.8.2 HEC Pharm Co. Limited Business Overview
7.8.3 HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Major Product Offerings
7.8.4 HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Sales and Revenue in Global (2018-2023)
7.8.5 HEC Pharm Co. Limited Key News & Latest Developments
8 Global Sphingosine-1-Receptor Modulators Drugs Production Capacity, Analysis
8.1 Global Sphingosine-1-Receptor Modulators Drugs Production Capacity, 2018-2030
8.2 Sphingosine-1-Receptor Modulators Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global Sphingosine-1-Receptor Modulators Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Sphingosine-1-Receptor Modulators Drugs Supply Chain Analysis
10.1 Sphingosine-1-Receptor Modulators Drugs Industry Value Chain
10.2 Sphingosine-1-Receptor Modulators Drugs Upstream Market
10.3 Sphingosine-1-Receptor Modulators Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Sphingosine-1-Receptor Modulators Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Key Players of Sphingosine-1-Receptor Modulators Drugs in Global Market
Table 2. Top Sphingosine-1-Receptor Modulators Drugs Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Sphingosine-1-Receptor Modulators Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Sphingosine-1-Receptor Modulators Drugs Revenue Share by Companies, 2018-2023
Table 5. Global Sphingosine-1-Receptor Modulators Drugs Sales by Companies, (K Units), 2018-2023
Table 6. Global Sphingosine-1-Receptor Modulators Drugs Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Sphingosine-1-Receptor Modulators Drugs Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Sphingosine-1-Receptor Modulators Drugs Product Type
Table 9. List of Global Tier 1 Sphingosine-1-Receptor Modulators Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Sphingosine-1-Receptor Modulators Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Global Sphingosine-1-Receptor Modulators Drugs Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Sphingosine-1-Receptor Modulators Drugs Revenue (US$, Mn), 2024-2030
Table 14. By Type - Global Sphingosine-1-Receptor Modulators Drugs Sales (K Units), 2018-2023
Table 15. By Type - Global Sphingosine-1-Receptor Modulators Drugs Sales (K Units), 2024-2030
Table 16. By Application ? Global Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2022 & 2030
Table 17. By Application - Global Sphingosine-1-Receptor Modulators Drugs Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Sphingosine-1-Receptor Modulators Drugs Revenue (US$, Mn), 2024-2030
Table 19. By Application - Global Sphingosine-1-Receptor Modulators Drugs Sales (K Units), 2018-2023
Table 20. By Application - Global Sphingosine-1-Receptor Modulators Drugs Sales (K Units), 2024-2030
Table 21. By Region ? Global Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2022 VS 2030
Table 22. By Region - Global Sphingosine-1-Receptor Modulators Drugs Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Sphingosine-1-Receptor Modulators Drugs Revenue (US$, Mn), 2024-2030
Table 24. By Region - Global Sphingosine-1-Receptor Modulators Drugs Sales (K Units), 2018-2023
Table 25. By Region - Global Sphingosine-1-Receptor Modulators Drugs Sales (K Units), 2024-2030
Table 26. By Country - North America Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2024-2030
Table 28. By Country - North America Sphingosine-1-Receptor Modulators Drugs Sales, (K Units), 2018-2023
Table 29. By Country - North America Sphingosine-1-Receptor Modulators Drugs Sales, (K Units), 2024-2030
Table 30. By Country - Europe Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2024-2030
Table 32. By Country - Europe Sphingosine-1-Receptor Modulators Drugs Sales, (K Units), 2018-2023
Table 33. By Country - Europe Sphingosine-1-Receptor Modulators Drugs Sales, (K Units), 2024-2030
Table 34. By Region - Asia Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2024-2030
Table 36. By Region - Asia Sphingosine-1-Receptor Modulators Drugs Sales, (K Units), 2018-2023
Table 37. By Region - Asia Sphingosine-1-Receptor Modulators Drugs Sales, (K Units), 2024-2030
Table 38. By Country - South America Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2024-2030
Table 40. By Country - South America Sphingosine-1-Receptor Modulators Drugs Sales, (K Units), 2018-2023
Table 41. By Country - South America Sphingosine-1-Receptor Modulators Drugs Sales, (K Units), 2024-2030
Table 42. By Country - Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2024-2030
Table 44. By Country - Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales, (K Units), 2024-2030
Table 46. Novartis Company Summary
Table 47. Novartis Sphingosine-1-Receptor Modulators Drugs Product Offerings
Table 48. Novartis Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Novartis Key News & Latest Developments
Table 50. Bristol-Myers Squibb Company Summary
Table 51. Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Product Offerings
Table 52. Bristol-Myers Squibb Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Bristol-Myers Squibb Key News & Latest Developments
Table 54. Johnson & Johnson Company Summary
Table 55. Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Product Offerings
Table 56. Johnson & Johnson Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Johnson & Johnson Key News & Latest Developments
Table 58. Arena Pharmaceuticals Company Summary
Table 59. Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Product Offerings
Table 60. Arena Pharmaceuticals Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Arena Pharmaceuticals Key News & Latest Developments
Table 62. Idorsia Company Summary
Table 63. Idorsia Sphingosine-1-Receptor Modulators Drugs Product Offerings
Table 64. Idorsia Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Idorsia Key News & Latest Developments
Table 66. Sun Pharma Company Summary
Table 67. Sun Pharma Sphingosine-1-Receptor Modulators Drugs Product Offerings
Table 68. Sun Pharma Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Sun Pharma Key News & Latest Developments
Table 70. Biocon Company Summary
Table 71. Biocon Sphingosine-1-Receptor Modulators Drugs Product Offerings
Table 72. Biocon Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Biocon Key News & Latest Developments
Table 74. HEC Pharm Co. Limited Company Summary
Table 75. HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Product Offerings
Table 76. HEC Pharm Co. Limited Sphingosine-1-Receptor Modulators Drugs Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. HEC Pharm Co. Limited Key News & Latest Developments
Table 78. Sphingosine-1-Receptor Modulators Drugs Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 79. Global Sphingosine-1-Receptor Modulators Drugs Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Sphingosine-1-Receptor Modulators Drugs Production by Region, 2018-2023 (K Units)
Table 81. Global Sphingosine-1-Receptor Modulators Drugs Production by Region, 2024-2030 (K Units)
Table 82. Sphingosine-1-Receptor Modulators Drugs Market Opportunities & Trends in Global Market
Table 83. Sphingosine-1-Receptor Modulators Drugs Market Drivers in Global Market
Table 84. Sphingosine-1-Receptor Modulators Drugs Market Restraints in Global Market
Table 85. Sphingosine-1-Receptor Modulators Drugs Raw Materials
Table 86. Sphingosine-1-Receptor Modulators Drugs Raw Materials Suppliers in Global Market
Table 87. Typical Sphingosine-1-Receptor Modulators Drugs Downstream
Table 88. Sphingosine-1-Receptor Modulators Drugs Downstream Clients in Global Market
Table 89. Sphingosine-1-Receptor Modulators Drugs Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Sphingosine-1-Receptor Modulators Drugs Segment by Type in 2022
Figure 2. Sphingosine-1-Receptor Modulators Drugs Segment by Application in 2022
Figure 3. Global Sphingosine-1-Receptor Modulators Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Sphingosine-1-Receptor Modulators Drugs Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Sphingosine-1-Receptor Modulators Drugs Revenue, 2018-2030 (US$, Mn)
Figure 7. Sphingosine-1-Receptor Modulators Drugs Sales in Global Market: 2018-2030 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Sphingosine-1-Receptor Modulators Drugs Revenue in 2022
Figure 9. By Type - Global Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 10. By Type - Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share, 2018-2030
Figure 11. By Type - Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share, 2018-2030
Figure 12. By Type - Global Sphingosine-1-Receptor Modulators Drugs Price (US$/Unit), 2018-2030
Figure 13. By Application - Global Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 14. By Application - Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share, 2018-2030
Figure 15. By Application - Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share, 2018-2030
Figure 16. By Application - Global Sphingosine-1-Receptor Modulators Drugs Price (US$/Unit), 2018-2030
Figure 17. By Region - Global Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2022 & 2030
Figure 18. By Region - Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share, 2018 VS 2022 VS 2030
Figure 19. By Region - Global Sphingosine-1-Receptor Modulators Drugs Revenue Market Share, 2018-2030
Figure 20. By Region - Global Sphingosine-1-Receptor Modulators Drugs Sales Market Share, 2018-2030
Figure 21. By Country - North America Sphingosine-1-Receptor Modulators Drugs Revenue Market Share, 2018-2030
Figure 22. By Country - North America Sphingosine-1-Receptor Modulators Drugs Sales Market Share, 2018-2030
Figure 23. US Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2030
Figure 24. Canada Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2030
Figure 25. Mexico Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2030
Figure 26. By Country - Europe Sphingosine-1-Receptor Modulators Drugs Revenue Market Share, 2018-2030
Figure 27. By Country - Europe Sphingosine-1-Receptor Modulators Drugs Sales Market Share, 2018-2030
Figure 28. Germany Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2030
Figure 29. France Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2030
Figure 30. U.K. Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2030
Figure 31. Italy Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2030
Figure 32. Russia Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2030
Figure 33. Nordic Countries Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2030
Figure 34. Benelux Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2030
Figure 35. By Region - Asia Sphingosine-1-Receptor Modulators Drugs Revenue Market Share, 2018-2030
Figure 36. By Region - Asia Sphingosine-1-Receptor Modulators Drugs Sales Market Share, 2018-2030
Figure 37. China Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2030
Figure 38. Japan Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2030
Figure 39. South Korea Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2030
Figure 40. Southeast Asia Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2030
Figure 41. India Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2030
Figure 42. By Country - South America Sphingosine-1-Receptor Modulators Drugs Revenue Market Share, 2018-2030
Figure 43. By Country - South America Sphingosine-1-Receptor Modulators Drugs Sales Market Share, 2018-2030
Figure 44. Brazil Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2030
Figure 45. Argentina Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2030
Figure 46. By Country - Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Revenue Market Share, 2018-2030
Figure 47. By Country - Middle East & Africa Sphingosine-1-Receptor Modulators Drugs Sales Market Share, 2018-2030
Figure 48. Turkey Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2030
Figure 49. Israel Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2030
Figure 50. Saudi Arabia Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2030
Figure 51. UAE Sphingosine-1-Receptor Modulators Drugs Revenue, (US$, Mn), 2018-2030
Figure 52. Global Sphingosine-1-Receptor Modulators Drugs Production Capacity (K Units), 2018-2030
Figure 53. The Percentage of Production Sphingosine-1-Receptor Modulators Drugs by Region, 2022 VS 2030
Figure 54. Sphingosine-1-Receptor Modulators Drugs Industry Value Chain
Figure 55. Marketing Channels
